Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Inhibition of HIV-1 Tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity.
Corallini A, Sampaolesi R, Possati L, Merlin M, Bagnarelli P, Piola C, Fabris M, Menegatti MA, Talevi S, Gibellini D, Rocchetti R, Caputo A, Barbanti-Brodano G.
Virology. 2002 Jul 20;299(1):1-7.
Related citations
HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells.
Deregibus MC, Cantaluppi V, Doublier S, Brizzi MF, Deambrosis I, Albini A, Camussi G.
J Biol Chem. 2002 Jul 12;277(28):25195-202. Epub 2002 May 6.
Bcl-2 upregulation by HIV-1 Tat during infection of primary human macrophages in culture.
Zhang M, Li X, Pang X, Ding L, Wood O, Clouse KA, Hewlett I, Dayton AI.
J Biomed Sci. 2002 Mar-Apr;9(2):133-9.
Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein.
Wang Z, Morris GF, Reed JC, Kelly GD, Morris CB.
Virology. 1999 May 10;257(2):502-10.
The human immunodeficiency virus type-1 (HIV-1) Tat protein and Bcl-2 gene expression.
Zauli G, Gibellini D.
Leuk Lymphoma. 1996 Nov;23(5-6):551-60. Review.
Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis.
Zauli G, Gibellini D, Milani D, Mazzoni M, Borgatti P, La Placa M, Capitani S.
Cancer Res. 1993 Oct 1;53(19):4481-5.
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells.
Zauli G, Gibellini D, Caputo A, Bassini A, Negrini M, Monne M, Mazzoni M, Capitani S.
Blood. 1995 Nov 15;86(10):3823-34.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on